Abstract
The effects of an oral dose of atropine (0.03 mg/kg body weight) and an IM (0.02 mg/kg) dose on the heart rate and salivary flow in seven healthy adult volunteers were compared to see whether the oral dose was sufficient to inhibit vagal reflexes of the heart. Atropine concentrations in plasma were determined by an M2-selective radioreceptor assay, and the in vitro occupancy of porcine cardiac M2-cholinoceptors was measured in parallel.
In ligand-binding studies, atropine has been shown to have a comparable affinity for human and porcine cardiac M2-cholinoceptors (Ki 4.0 and 5.9, respectively). Slight changes in heart rate after oral administration were not significant. After IM administration, however, the heart rate increased significantly, by a maximum of 22 beats·min−1 after 45 min. The slight increase in heart rate after the oral dose corresponded to a receptor occupancy in vitro near the lower limit of detection, whereas the significant increase in heart rate after the IM dose corresponded to a receptor occupancy of up to 47%. The maximum reduction in salivary flow was similar after the oral and IM doses (84.3 and 87.5%, respectively).
The almost complete inhibition of salivary flow could be explained by the lower vagal tone in the salivary glands compared with to the heart. The difference in the effect on heart rate was probably due to lower absorption of the oral dose. Thus, an oral dose greater than 0.03 mg atropine/kilogram body weight is required to compensate for low gastrointestinal absorption and to overcome the high vagal tone of the heart.
Similar content being viewed by others
References
Fassoulaki A, Kaniaris P (1982) Does atropine premedication affect the cardiovascular response to laryngoscopy and intubation? Br J Anaesth 54:1065–1069
Kanto J (1983) New aspects in the use of atropine. Int J Clin Pharmacol Ther Toxicol 21:92–94
Mirakhur RK, Clarke RSJ, Elliot J, Dundee JW (1978) Atropine and glycopyrronium premedication: A comparison of the effects on cardiac rate and rhythm during induction of anaesthesia. Anaesthesia 33:906–912
Eger II IE (1962) Atropine, scopolamine, and related compounds. Anesthesiology 23:365–383
Holt AT (1962) Premedication with atropine should not be routine. Lancet 2:984–985
Sjövall S, Kanto J, Iisalo E, Himberg JJ, Kangas L (1984) Midazolam versus atropine plus pethidine as premedication in children. Anaesthesia 39:224–228
Steward DJ (1983) Anticholinergic premedication for infants and children. Can Anaesth Soc J 30:683–684
Badgwell JM, Heavner JE, Cooper MW, Cockings E (1988) The cardiovascular effects of anticholinergic agents administered during halothane anaesthesia in children. Acta Anaesthesiol Scand 32:383–387
Hendrickx P, Govaerts MGM (1980) Pediatric premedication: atropine or not? Acta Anaesthesiol Belg 31:277–281
Saarnivaara L, Kautto UM, Iisalo E, Pihlajamäki K (1985) Comparison of pharmacokinetic and pharmacodynamic parameters following oral or intramuscular atropine in children. Atropine overdose in two small children. Acta Anaesthesiol Scand 29:529–536
Wellstein A, Belz GG, Palm D (1988) Beta-adrenoceptor subtype binding activity in plasma and beta-blockade by propranolol and beta-1 selective bisoprolol in humans: evaluation with Schild plots. J Pharmacol Exp Ther 246:328–337
Pitschner HF, Schulte B, Schlepper M, Palm D, Wellstein A (1989) AF-DX 116 discriminates heart from gland M2-cholinoceptors in man. Life Sci 45:493–498
Wellstein A, Pitschner HF (1988) Complex dose-response curves of atropine in man explained by different functions of M1- and M2-cholinoceptors. Naunyn Schmiedeberg's Arch Pharmacol 338:19–27
Schulte B, Volz-Zang C, Mutschler E, Horne C, Palm D, Wellstein A, Pitschner HF (1991) AF-DX 116, a cardioselective muscarinic antagonist in humans: Pharmacodynamic and pharmacokinetic properties. Clin Pharmacol Ther 50:372–378
Dollery CT, Davies DS, Draffan GH, Dargie HJ, Dean CR, Reid JC, Clare RA, Murray S (1975) Clinical pharmacology and pharmacokinetics of clonidine. Clin Pharmacol Ther 19:11–17
Van Hooff M, Van Baak MA, Schols M, Rahn KH (1984) Studies of salivary flow in borderline hypertension: effects of drugs acting on structures innervated by the autonomic nervous system. Clin Sci 66:599–604
Deighton NM, Matomura S, Borquez D, Zerkowski HR, Doetsch N, Brodde OE (1990) Muscarinic cholinoceptors in the human heart: demonstration, sub-classification and distribution. Naunyn Schmiedeberg's Arch Pharmacol 341:14–21
Giraldo E, Micheletti E, Montagna E, Giachetti A, Vigano MA, Melchiorre C (1988) Binding and functional characterization of the cardioselective muscarinic antagonist methoctramine. J Pharmacol Exp Ther 244:1016–1020
Author information
Authors and Affiliations
Additional information
The results form part of the thesis of T. Waldhäuser
Rights and permissions
About this article
Cite this article
Volz-Zang, C., Waldhäuser, T., Palm, D. et al. Comparison of the effects of atropine in vivo and ex vivo (radioreceptor assay) after oral and intramuscular administration to man. Eur J Clin Pharmacol 49, 45–49 (1995). https://doi.org/10.1007/BF00192357
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00192357